Evidence map›Paper›PMID 39224771›Full record

ArticleAmerican journal of preventive cardiology2024

Bempedoic Acid in Secondary Prevention.

Idine Mousavi, Vijay Nambi, Layla A Abushamat, Sadeer G Al-Kindi, Michael D Shapiro, Laurence Sperling, Salim S Virani, Abdul Mannan Khan Minhas

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Idine MousaviDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA.
Vijay NambiDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA.
Layla A AbushamatDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA.
Sadeer G Al-KindiDepartment of Cardiology, Houston Methodist Hospital, TX, USA.
Michael D ShapiroSection on Cardiovascular Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Laurence SperlingDivision of Cardiology, Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA, USA.
Salim S ViraniDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA.
Abdul Mannan Khan MinhasDepartment of Medicine, Baylor College of Medicine, Houston, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•Bempedoic acid has been shown to reduce major adverse cardiovascular outcomes in patients unable to take statins due to statin-associated side effects.•Analysis of CLEAR Outcomes trial data reveals possible differences in baseline characteristics between the primary and secondary prevention subgroups.•Further research is needed to optimize use of bempedoic acid and clarify its impact on cardiovascular outcomes in diverse patient populations.

Identifiers

PMID39224771
PMCPMC11367048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.